Digital Event, Zoom
30/06/2021 – 02/07/2021
Diets that produce smaller excursions in postprandial plasma glucose and insulin concentrations are associated with a wide range of health benefits, including improved insulin secretion and sensitivity, and thus enhanced glycaemic control. The European Food Safety Authority therefore considers the reduction of postprandial glucose may be physiologically beneficial, if not accompanied by a disproportionate increase in insulin (EFSA, 2012).
In childhood, the immediate benefits of lowering blood glucose excursions (or deleterious effect of higher excursions) may be relatively small, but longer-term effects can be potentially large when adopted and sustained over a lifetime. However, a clear consensus on the potential benefits is currently lacking).
The aim of the workshop will be to discuss the literature on the impact of lowering post-prandial glycaemic responses on health outcomes in infancy, childhood and adolescence. The role of limiting high glycaemic excursions for metabolic disease prevention will be debated, with a specific focus on glycaemic control and risk markers related to metabolic disease prevention (Type 2 diabetes and cardiovascular disease).
The outcomes of the workshop will be published as proceedings to reflect the state of the art in the field.
• Prof. Anette Buyken – Chair, University of Paderborn (DE)
• Dr Sophie Vinoy – Co- Chair, Mondelez (FR)
• Dr Janina Goletzke, University of Paderborn (DE)
• Dr Jose Maria Lopez-Pedrosa, Abbott Nutrition (ES)
• Dr Maryam Rakhshandehroo, Danone (NL)
• Dr Lisa Schweitzer, BENEO / Südzucker Group (DE)
• Dr Julia Zakrzewski-Fruer, University of Bedfordshire (UK)
• Dr Matthieu Flourakis, ILSI Europe (BE)
For more information on this digital event, please contact Dr Matthieu Flourakis, Scientific Project Manager at firstname.lastname@example.org.